Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Insmed Inc (INSM)

Insmed Inc (INSM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,792,000
  • Shares Outstanding, K 89,344
  • Annual Sales, $ 9,840 K
  • Annual Income, $ -324,280 K
  • 60-Month Beta 3.12
  • Price/Sales 25.30
  • Price/Cash Flow N/A
  • Price/Book 8.94

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.58
  • Number of Estimates 5
  • High Estimate -0.42
  • Low Estimate -0.66
  • Prior Year -1.17
  • Growth Rate Est. (year over year) +50.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.43 +60.83%
on 01/27/20
34.94 -10.56%
on 02/06/20
+10.36 (+49.63%)
since 01/21/20
3-Month
19.43 +60.83%
on 01/27/20
34.94 -10.56%
on 02/06/20
+10.35 (+49.52%)
since 11/21/19
52-Week
15.33 +103.85%
on 08/15/19
34.94 -10.56%
on 02/06/20
+5.68 (+22.21%)
since 02/21/19

Most Recent Stories

More News
Insmed to Present at the 9th Annual SVB Leerink Global Healthcare Conference

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that Will Lewis, Chairman and Chief...

INSM : 31.25 (+2.69%)
Insmed Inc Falls 2.90% on Heavy Volume: Watch For Potential Rebound

Insmed Inc (NASDAQ:INSM) traded in a range yesterday that spanned from a low of $31.30 to a high of $32.58. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $32.03...

INSM : 31.25 (+2.69%)
Insmed to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call on Tuesday, February 25, 2020

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its fourth quarter...

INSM : 31.25 (+2.69%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to...

INSM : 31.25 (+2.69%)
R&D Leading to Supported Progress for Treating Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia (AML) research has seen great progress with more researchers are now studying the causes, diagnosis, and treatment of Acute myeloid leukemia (AML) at many medical centers, university...

MBRX : 0.77 (-2.53%)
LJPC : 8.12 (-1.58%)
INSM : 31.25 (+2.69%)
TEVA : 13.19 (-0.90%)
PBYI : 13.60 (-2.58%)
Relatively Good Performance Detected in Shares of La Jolla Pharm in the Biotechnology Industry (LJPC , INSM , FOLD , GBT , PTLA )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

FOLD : 10.78 (-0.46%)
INSM : 31.25 (+2.69%)
LJPC : 8.12 (-1.58%)
Company News for Feb 4, 2020

Companies in the news are: GILD, MAXR, INSM, ABG

ABG : 99.49 (-0.25%)
GILD : 69.70 (+4.03%)
INSM : 31.25 (+2.69%)
MAXR : 17.26 (-2.27%)
Gilead, Insmed rise; ON Semiconductor, Pacific Premier fall

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Monday:

PPBI : 30.26 (-0.85%)
OPB : 27.79 (+0.18%)
ENR : 51.38 (+0.02%)
EPC : 34.03 (-0.96%)
ON : 20.01 (-2.84%)
INSM : 31.25 (+2.69%)
GILD : 69.70 (+4.03%)
ABG : 99.49 (-0.25%)
BIDU : 129.80 (-2.01%)
Insmed Inc Set to Possibly Pullback After Yesterday's Rally of 34.81%

Insmed Inc (NASDAQ:INSM) traded in a range yesterday that spanned from a low of $27.02 to a high of $30.44. Yesterday, the shares gained 34.8%, which took the trading range above the 3-day high of $21.19...

INSM : 31.25 (+2.69%)
Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchiectasis

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced positive top-line results from its...

INSM : 31.25 (+2.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade INSM with:

Business Summary

Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas...

See More

Key Turning Points

2nd Resistance Point 32.36
1st Resistance Point 31.81
Last Price 31.25
1st Support Level 30.35
2nd Support Level 29.44

See More

52-Week High 34.94
Last Price 31.25
Fibonacci 61.8% 27.45
Fibonacci 50% 25.13
Fibonacci 38.2% 22.82
52-Week Low 15.33

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar